OUTSET MEDICAL INC (OM) Stock Analyst Ratings
USA - NASDAQ:OM - US6901452069 - Common Stock
14.78 USD
-0.42 (-2.76%)
ChartMill assigns a Buy % Consensus number of 85% to OM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 26.27. This target is 77.71% above the current price.
OM was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about OM.
In the previous month the buy percentage consensus was at a similar level.
OM was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-19 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-01-07 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-08 | TD Cowen | Maintains | Buy -> Buy |
| 2024-08-08 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-06-21 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2024-04-08 | BTIG | Initiate | Buy |
| 2024-01-12 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-12-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-10-13 | Stifel | Maintains | Buy -> Buy |
| 2023-10-13 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-08-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-17 | CL King | Initiate | Neutral |
| 2023-08-17 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-08-03 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-04 | RBC Capital | Maintains | Outperform |
| 2023-01-06 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-11 | RBC Capital | Initiate | Outperform |
| 2022-11-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-09 | Goldman Sachs | Maintains | Buy |
| 2022-10-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-03 | Goldman Sachs | Maintains | Buy |
| 2022-08-02 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-18 | Stifel | Maintains | Buy |
OUTSET MEDICAL INC / OM FAQ
What is the price target for OM stock?
12 analysts have analysed OM and the average price target is 26.27 USD. This implies a price increase of 77.71% is expected in the next year compared to the current price of 14.78.
What is the consensus rating for OM stock?
The consensus rating for OUTSET MEDICAL INC (OM) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.